Related Experiment Videos
Intravenous immunoglobulin and dendritic cells
Namita Misra1, Jagadeesh Bayry, Jagadeesh Bayary
1Inserm, U681, Paris, France.
Clinical Reviews in Allergy & Immunology
|January 5, 2006
Summary
Intravenous immunoglobulin (IVIg) is a therapy for immune disorders. This study shows IVIg impacts dendritic cell (DC) function, indicating DCs are a target for IVIg's immunomodulatory effects.
Area of Science:
- Immunology
- Cell Biology
Background:
- Intravenous immunoglobulin (IVIg) is increasingly used for autoimmune diseases, inflammatory conditions, and immunodeficiencies.
- Evidence suggests IVIg benefits various immune-mediated conditions, including those involving autoantibodies or T-cells.
Purpose of the Study:
- To investigate the effects of IVIg on dendritic cells (DCs).
- To determine if DCs are a target for IVIg's immunomodulatory actions.
Main Methods:
- Examined the impact of IVIg on DC differentiation, maturation, and function.
- Utilized in vitro experimental models.
Main Results:
- Demonstrated that IVIg influences the differentiation and maturation of DCs.
- Showed that IVIg affects the functions of DCs.
Conclusions:
- Dendritic cells are identified as a cellular target for the immunomodulatory effects of IVIg.
- These findings support a mechanism for IVIg in treating immune-mediated diseases.